Pharmaron Beijing (HKG:3759, SHE:300759) plans to buy back up to 50 million yuan of H shares, according to a Monday filing with the Hong Kong Exchange.
The Chinese drug developer is set to repurchase up to 15,076,856 shares, or 5% of its total H-share count, the filing said.
Shares jumped 1% during Monday's afternoon trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments